Literature DB >> 20947546

Do Asian patients have worse lupus?

M Y Mok1, W L Li.   

Abstract

The predisposition to and clinical phenotype of systemic lupus erythematosus, an autoimmune disease that is associated with significant morbidity and mortality, are affected by genetic and environmental factors. This article aims to examine whether Asians have worse lupus by reviewing the literature on genetic predisposition and clinical outcomes, including major organ involvement, damage score and mortality in Asian populations compared with other ethnicities. A number of lupus nephritis susceptibility genes have been identified in Asians and White patients, with further variations among different Asian populations. Meta-analysis studies on various Fcγ receptor subtypes revealed that FcγRIIIA-F158 allele, which is associated with low binding affinity to IgG1 and IgG3, predisposed to lupus nephritis in Asian patients. Asian patients were reported to have higher rates of lupus nephritis-associated autoantibodies, lupus nephritis and more active glomerulonephritis compared with White patients. Renal outcome and the level of immunosuppressant use in Asians were comparable to Afro-American Blacks in some studies. Asians were also found to have higher overall damage scores compared with Whites. The difference in mortality between Asian patients and other ethnicities in different geographical regions was found to vary depending on socioeconomic factors such as access to health care. Poverty, education level, cultural and behavioural factors are confounders to ethnicity in determining clinical outcome of systemic lupus erythematosus.

Entities:  

Mesh:

Year:  2010        PMID: 20947546     DOI: 10.1177/0961203310375832

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  20 in total

1.  Association of Traditional Chinese Medicine Use With Adherence to Prescribed Western Rheumatic Medications Among Chinese American Patients: A Cross-Sectional Survey.

Authors:  Kai Sun; Jackie Szymonifka; Henghe Tian; Yaju Chang; Jennifer C Leng; Lisa A Mandl
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-10       Impact factor: 4.794

2.  Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.

Authors:  Jayne Little; Ben Parker; Mark Lunt; John G Hanly; Murray B Urowitz; Ann E Clarke; Juanita Romero-Diaz; Caroline Gordon; Sang-Cheol Bae; Sasha Bernatsky; Daniel J Wallace; Joan T Merrill; Jill Buyon; David A Isenberg; Anisur Rahman; Ellen M Ginzler; Michelle Petri; Mary Anne Dooley; Paul Fortin; Dafna D Gladman; Kristjan Steinsson; Rosalind Ramsey-Goldman; Munther A Khamashta; Cynthia Aranow; Meggan Mackay; Graciela S Alarcón; Susan Manzi; Ola Nived; Andreas Jönsen; Asad A Zoma; Ronald F van Vollenhoven; Manuel Ramos-Casals; Guillermo Ruiz-Irastorza; Sung Sam Lim; Kenneth C Kalunian; Murat Inanc; Diane L Kamen; Christine A Peschken; Soren Jacobsen; Anca Askanase; Jorge Sanchez-Guerrero; Ian N Bruce
Journal:  Rheumatology (Oxford)       Date:  2018-04-01       Impact factor: 7.580

3.  Is Traditional Chinese Medicine Use Associated with Worse Patient-reported Outcomes among Chinese American Rheumatology Patients?

Authors:  Kai Sun; Jackie Szymonifka; Henghe Tian; Yaju Chang; Jennifer C Leng; Lisa A Mandl
Journal:  J Rheumatol       Date:  2019-05-01       Impact factor: 4.666

4.  Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus.

Authors:  Medha Barbhaiya; Candace H Feldman; Hongshu Guan; Jose A Gómez-Puerta; Michael A Fischer; Daniel H Solomon; Brendan Everett; Karen H Costenbader
Journal:  Arthritis Rheumatol       Date:  2017-08-13       Impact factor: 10.995

5.  The Sarawak lupus cohort: clinical features and disease patterns of 633 SLE patients in a single tertiary centre from East Malaysia.

Authors:  C L Teh; G R Ling; Wan Sharifah Aishah
Journal:  Rheumatol Int       Date:  2014-06-07       Impact factor: 2.631

Review 6.  Lupus Nephritis: A Different Disease in European Patients?

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Kidney Dis (Basel)       Date:  2015-08-28

Review 7.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

8.  Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.

Authors:  José A Gómez-Puerta; Medha Barbhaiya; Hongshu Guan; Candace H Feldman; Graciela S Alarcón; Karen H Costenbader
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

9.  Brief Report: Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians.

Authors:  Rachel Kaiser; Kimberly E Taylor; Yun Deng; Jian Zhao; Yonghong Li; Joanne Nititham; Monica Chang; Joseph Catanese; Ann B Begovich; Elizabeth E Brown; Jeffrey C Edberg; Gerald McGwin; Graciela S Alarcón; Rosalind Ramsey-Goldman; John D Reveille; Luis M Vila; Michelle Petri; Robert P Kimberly; Xuebing Feng; Lingyun Sun; Nan Shen; Wei Li; Jian-Xin Lu; Edward K Wakeland; Quan-Zhen Li; Wanling Yang; Yu-Lung Lau; Fei-Lan Liu; Deh-Ming Chang; Chack-Yung Yu; Yeong W Song; Betty P Tsao; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2013-01

10.  Targeting HER2 beyond breast cancer.

Authors:  Sanchita Bhatnagar; Jogender Tushir-Singh
Journal:  Mol Cell Oncol       Date:  2019-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.